BRENDAN BRENNAN

Chief Finance Officer

Brendan will join HBX Group in October 2024 from global clinical research provider, the publicly listed ICON plc, where his career has spanned almost 19 years, 13 of which as Chief Finance Officer ( CFO).

A strategic-minded senior executive with extensive experience driving out-performance at revenue and earnings levels global organisations, Brendan has a proven track record of cost management, efficiency creation, and significant M&A experience, including the $12 billion acquisition and integration of PRA Health Sciences.

Brendan also brings extensive experience in public listed companies including investor relations, board-level reporting and presenting to public company sub-committees. He has worked with teams across the Americas, Europe, and Asia, managing a 41,000-FTE organisation.

Prior to his role at ICON, Brendan held various senior positions in financial planning, corporate finance, and investor relations. He has also worked with CRH Plc and PWC.

In addition to his finance responsibilities, Brendan will also oversee Investor Relations, Legal, Procurement, Property and the Pricing Centre of Excellence. GRC and Audit continues to report directly to the Board.